Market Research > Healthcare > Nonprescription Drugs USA

Market Research Reports: Nonprescription Drugs

Nonprescription Drugs USA

Base year: 2016
Data Released March 2017
Report Published June 2017
View Brochure
Base year: 2017
Data to be Released March 2018
Report to be Published June 2018
View Brochure
Download Brochure Price & Ordering
  • Description
  • Regional Coverage: United States
    Request Fact Sheet
    Download Infographic


    A comprehensive analysis of the U.S. nonprescription drugs industry, focusing on key trends, developments, challenges, business opportunities, and new product activity, and offers insights and information on the following:

    • Industry trends
    • Market size and performance
    • Brand sales and share
    • Company sales and share
    • New product activity
    • Retail distribution
    • Regulatory developments
    • Rx-to-OTC switch forecasts
    • Five-year historical sales
    • Five-year sales forecasts

    Features user-friendly database that is fully searchable and exportable that contains sales data, growth, share, and forecasts for hundreds of brands and companies across more than 20 categories. Through its alliance with IRI, Kline now includes as part this report analysis of IRI MULO data for year ending 2017.

  • Contents
  • Introduction

    Executive Summary
    An executive briefing covering developments in 2017, the impact of key trends and issues in the nonprescription drug business, and their future implications for industry participants. Includes analysis of retail distribution, private-label activity, and fiveyear forecasts through 2022.

    Pertinent information plus insightful analysis of approximately 22 major categories, including key trends and developments; manufacturers’ sales for 2016 and 2017, sales and market shares for leading brands, new product activity, sales by retail channel, private-label sales, marketing activity, and outlook to 2022. The product categories covered are shown in Table 1.

    Major Companies
    Profiles for 11 major companies, including company activities; sales by product category and major brands in 2016 and 2017; recent developments including acquisitions, divestitures, and new products; corporate overview; and an outlook to 2022. The major companies covered are shown in Table 2.

    *Subject to charter subscriber input

    Table 1: Product Categories Profiled

    Digestive Products

    Topical Products

    • Antacids and antigas
    • Antidiarrheal preparations
    • Antinausea preparations
    • Laxatives

    • Anti-itch products
    • Corn, callus, and wart removers
    • Diaper rash products
    • Eye care products
    • First aid products
    • Fungicidal preparations
    • Oral care products
    • Topical analgesics

    Internal Analgesics

    Upper Respiratory Products

    • General pain relievers
    • Other internal analgesics
    • Oral care products
    • Topical analgesics

    • Allergy and asthma relief products
    • Cold and sinus medications
    • Cough drops and sore throat remedies
    • Cough syrups
    • Nasal and topical decongestants

    Nutritional Products

    Other Products

    • Herbal products
    • Vitamins and minerals

    • Sleeping aids

    Table 2: Major Companies Profiled
    Bayer Group
    Carlyle Group
    Church & Dwight
    Johnson & Johnson
    Prestige Brands
    Procter & Gamble
    Reckitt Benckiser
  • Scope
  • Nonprescription Drugs USA is an extensive industry resource used widely by marketing executives and other industry participants for competitive analysis, market investigation for new products, acquisition screening, and business planning. This report focuses solely on nonprescription drugs sold through domestic consumer outlets, including those marketed via drug stores, food stores, and mass merchandisers, in addition to nontraditional outlets such as health food stores, convenience stores, warehouse clubs, dollar stores, mail order, and the Internet. Market data refer exclusively to sales through these outlets. Direct and mail order sales are included, but sales to institutions such as hospitals and nursing homes and exports are excluded.

    For more than 50 years, the study has proven to be the most authoritative and comprehensive annual source of information on the nonprescription drug industry. It contains industry trends and market size data for 22 product categories. In addition, market share and brand sales information are reported. The study profiles 11 leading major companies. Included in the report is an analysis of regulatory developments, retail distribution, and private-label.

  • Key Benefits
  • Subscribers to Nonprescription Drugs USA are afforded the following benefits:

    • Access to the most comprehensive and authoritative independent source of information and insights on the U.S. nonprescription drugs industry
    • Access to accurate sales data through all outlets based on primary research with knowledgeable industry participants
    • Invitation to participate in Kline’s annual web conference with access to Kline’s analysts and an in-depth presentation about market performance and industry trends
    • A tool to learn about categories or brands that could be potential new entry/acquisition opportunities
    • Access to periodic podcasts on timely topics from Kline’s industry experts
    • A source of valuable competitive information and intelligence
    • Understand industry trends that may impact your categories and/or brands
    • Learn about expected future Rx-to-OTC switches and their expected impacts on existing OTC categories
    • Depth of knowledge with historical sales and trend information, as well as five-year sales forecasts
    • Assessment of new product activity in each category
    • Access to Kline’s searchable, exportable database with sales data on hundreds of brands and companies across 22 categories
  • Methodology
  • Kline’s approach places the principal emphasis on primary research techniques to ensure that the foundation of business intelligence and insight is accurate, current, and reliable. Building on our 50-plus years in the business and leveraging our worldwide network of offices, our teams of seasoned professionals draw upon pragmatic industrial and commercial experience to understand and interpret global impacts and local perspectives.

    Primary Research
    We Know Who to Talk to. We Know How to Listen.

    A high number of in-depth discussions are conducted by each analyst. Up to 60% of interviews are done with the true industry insiders!

    Kline’s analysts draw upon pragmatic experience to understand global impacts and local perspectives. Our interviews engage experts across all pertinent fields and sectors including:

    • Marketers/manufacturers
    • Government agencies
    • Retailers
    • Trade organizations

    Secondary Research
    We Know Where to Look – Mining the Details.

    Analysis is further supplemented by secondary research, consisting of constant tracking of annual company reports, national statistics bureaus, trade/industrial/ professional associations, and the like. Through its alliance with IRI, Kline now includes as part of this report analysis of IRI MULO data for year ending 2017 and other secondary sources. Relevant developments are diligently followed and their impact closely monitored. Reports also draw upon non-confidential data from Kline’s internal database, consisting of over half a century’s syndicated research.

    Comprehensive Market Intelligence
    We Know How to Verify.

    Data are rigorously analyzed, cross-checked, distilled and validated. Kline’s proven methodology allows exceptionally effective, precise and reliable market intelligence procurement and assessment, giving subscribers a solid foundation on which to grow, refine and expand their business with confidence.

    Kline Credentials

    Kline is a leading global management consulting and market research firm offering the complete spectrum of services. The firm has served the management consulting and market research needs of organizations in the chemicals, materials, energy, life sciences, and consumer products industries for over 50 years.

Share this: Email This Page

Related Reports
Digestive Health, Immunity, and Probiotics: U.S. Market Analysis and Opportunities
Rx-to-OTC Switch USA: Next Frontier
50 Years of OTC Research
An evolution of the U.S. OTC market since 1963 >>

Industry Expert

Laura Mahecha   Laura Mahecha

Sales Contacts

Pilar Pardo   Pilar Pardo
Kristy Altenburg   Kristy Altenburg
Contact Kline Market Research   View all contacts
Market Research Reports   Purchase a Report
  Healthcare Portfolio
  Knowledge Hub
Custom Research
Can’t find exactly what you’re looking for? Consider a custom report.